These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3003544)

  • 1. Studies of latent cytomegalovirus infection: the macrophage as a virus-harboring cell.
    Hayashi K; Saze K; Uchida Y
    Microbiol Immunol; 1985; 29(7):625-34. PubMed ID: 3003544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency.
    Brautigam AR; Dutko FJ; Olding LB; Oldstone MB
    J Gen Virol; 1979 Aug; 44(2):349-59. PubMed ID: 230287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of latent murine cytomegalovirus in vivo and in vitro: a pathogenetic role for acute infection.
    Jordan MC; Takagi JL; Stevens JG
    J Infect Dis; 1982 May; 145(5):699-705. PubMed ID: 6281340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections.
    Mercer JA; Wiley CA; Spector DH
    J Virol; 1988 Mar; 62(3):987-97. PubMed ID: 2828694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction.
    Olding LB; Jensen FC; Oldstone MB
    J Exp Med; 1975 Mar; 141(3):561-72. PubMed ID: 163887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication of virus.
    Jordan MC; Mar VL
    J Clin Invest; 1982 Oct; 70(4):762-8. PubMed ID: 6288769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of macrophages in mice infected with murine cytomegalovirus.
    Mims CA; Gould J
    J Gen Virol; 1978 Oct; 41(1):143-53. PubMed ID: 212513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lethal infection with murine cytomegalovirus after early viral replication in the spleen.
    Katzenstein DA; Yu GS; Jordan MC
    J Infect Dis; 1983 Sep; 148(3):406-11. PubMed ID: 6311909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of latent murine cytomegalovirus infection: cocultivation, cell transfer, and the effect of immunosuppression.
    Mayo D; Armstrong JA; Ho M
    J Infect Dis; 1978 Dec; 138(6):890-6. PubMed ID: 216752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice.
    Yuhasz SA; Dissette VB; Cook ML; Stevens JG
    Virology; 1994 Jul; 202(1):272-80. PubMed ID: 8009839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of murine cytomegalovirus ocular infection. Anterior chamber inoculation.
    Bale JF; O'Neil ME; Lyon B; Perlman S
    Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1575-81. PubMed ID: 2167300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent cytomegalovirus infection of BALB/c mouse spleens detected by an explant culture technique.
    Wise TG; Manischewitz JE; Quinnan GV; Aulakh GS; Ennis FA
    J Gen Virol; 1979 Aug; 44(2):551-6. PubMed ID: 230295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of acute murine cytomegalovirus infection in resistant and susceptible strains of mice.
    Mercer JA; Spector DH
    J Virol; 1986 Feb; 57(2):497-504. PubMed ID: 3003382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latency, without persistence, of murine cytomegalovirus in the spleen and kidney.
    Pollock JL; Virgin HW
    J Virol; 1995 Mar; 69(3):1762-8. PubMed ID: 7853515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the production of murine cytomegalovirus and interferon in macrophages.
    Yamaguchi T; Shinagawa Y; Pollard RB
    J Gen Virol; 1988 Dec; 69 ( Pt 12)():2961-71. PubMed ID: 2462012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of murine cytomegalovirus DNA in circulating leukocytes harvested during acute infection of mice.
    Bale JF; O'Neil ME
    J Virol; 1989 Jun; 63(6):2667-73. PubMed ID: 2542580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of biological response modifiers on chronic and latent murine cytomegalovirus infections.
    Okada M; Minamishima Y
    Microbiol Immunol; 1987; 31(5):435-47. PubMed ID: 2443815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent murine cytomegalovirus infection in macrophages.
    Pollock JL; Presti RM; Paetzold S; Virgin HW
    Virology; 1997 Jan; 227(1):168-79. PubMed ID: 9007070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies.
    Farrell HE; Shellam GR
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():149-56. PubMed ID: 1846643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.